(SWBI) Smith & Wesson Brands - Ratings and Ratios
Handguns, Long Guns, Handcuffs, Suppressors, Parts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.52% |
| Yield on Cost 5y | 3.48% |
| Yield CAGR 5y | 15.72% |
| Payout Consistency | 100.0% |
| Payout Ratio | 2.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 43.9% |
| Value at Risk 5%th | 50.3% |
| Relative Tail Risk | -30.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.34 |
| Alpha | -1.02 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.585 |
| Beta | 0.596 |
| Beta Downside | 0.379 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.24% |
| Mean DD | 22.05% |
| Median DD | 16.27% |
Description: SWBI Smith & Wesson Brands December 27, 2025
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) designs, manufactures, and sells a full spectrum of firearms-including handguns, modern sporting rifles, pistol-caliber carbines, and lever-action rifles-as well as ancillary products such as suppressors, handcuffs, and custom-molded components. The firm also offers contract-manufacturing services (forging, heat treating, rapid prototyping, tooling, finishing, machining, and plastic injection molding) to third-party customers, and distributes its products through independent dealers, retail chains, direct-to-consumer channels, and range-operations.
Key performance indicators from the most recent fiscal year (2023) show revenue of approximately $1.6 billion, a 7 % YoY increase driven largely by higher demand for long-gun platforms and aftermarket accessories. Adjusted EBITDA margin expanded to roughly 12 % as the company leveraged its in-house manufacturing capabilities to improve cost efficiency. The civilian firearms market in the United States remains valued at about $12 billion, with a projected CAGR of 3-4 % through 2028, providing a sizable addressable base for SWBI’s product lines.
Sector-level drivers that materially affect SWBI’s outlook include: (1) the U.S. political environment-election cycles and legislative proposals on gun ownership can cause short-term demand volatility; (2) discretionary consumer spending trends, which are sensitive to macro-economic conditions such as inflation and employment levels; and (3) defense-budget allocations, as military and law-enforcement contracts represent a growing share of the company’s revenue mix.
For a data-rich, unbiased deep-dive into SWBI’s valuation metrics and scenario analysis, consider exploring the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (9.90m TTM) > 0 and > 6% of Revenue (6% = 28.0m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 5.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.02% (prev 44.47%; Δ 1.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 50.1m > Net Income 9.90m (YES >=105%, WARN >=100%) |
| Net Debt (101.1m) to EBITDA (44.0m) ratio: 2.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.7m) change vs 12m ago -0.44% (target <= -2.0% for YES) |
| Gross Margin 25.93% (prev 30.21%; Δ -4.28pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 82.11% (prev 87.61%; Δ -5.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.14 (EBITDA TTM 44.0m / Interest Expense TTM 5.06m) >= 6 (WARN >= 3) |
Altman Z'' 8.78
| (A) 0.39 = (Total Current Assets 268.5m - Total Current Liabilities 53.9m) / Total Assets 548.6m |
| (B) 0.95 = Retained Earnings (Balance) 519.5m / Total Assets 548.6m |
| warn (B) unusual magnitude: 0.95 — check mapping/units |
| (C) 0.03 = EBIT TTM 15.9m / Avg Total Assets 568.0m |
| (D) 2.80 = Book Value of Equity 519.5m / Total Liabilities 185.4m |
| Total Rating: 8.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.43
| 1. Piotroski 4.50pt |
| 2. FCF Yield 6.40% |
| 3. FCF Margin 7.82% |
| 4. Debt/Equity 0.34 |
| 5. Debt/Ebitda 2.30 |
| 6. ROIC - WACC (= -4.38)% |
| 7. RoE 2.71% |
| 8. Rev. Trend -33.02% |
| 9. EPS Trend -67.33% |
What is the price of SWBI shares?
Over the past week, the price has changed by +1.80%, over one month by +3.38%, over three months by +8.75% and over the past year by +8.20%.
Is SWBI a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SWBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 25.9% |
| Analysts Target Price | 13.5 | 25.9% |
| ValueRay Target Price | 11.7 | 9% |
SWBI Fundamental Data Overview January 14, 2026
P/S = 1.016
P/B = 1.29
Revenue TTM = 466.4m USD
EBIT TTM = 15.9m USD
EBITDA TTM = 44.0m USD
Long Term Debt = 89.0m USD (from longTermDebt, last quarter)
Short Term Debt = 1.78m USD (from shortTermDebt, last quarter)
Debt = 123.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 101.1m USD (from netDebt column, last quarter)
Enterprise Value = 570.1m USD (473.9m + Debt 123.6m - CCE 27.3m)
Interest Coverage Ratio = 3.14 (Ebit TTM 15.9m / Interest Expense TTM 5.06m)
EV/FCF = 15.63x (Enterprise Value 570.1m / FCF TTM 36.5m)
FCF Yield = 6.40% (FCF TTM 36.5m / Enterprise Value 570.1m)
FCF Margin = 7.82% (FCF TTM 36.5m / Revenue TTM 466.4m)
Net Margin = 2.12% (Net Income TTM 9.90m / Revenue TTM 466.4m)
Gross Margin = 25.93% ((Revenue TTM 466.4m - Cost of Revenue TTM 345.5m) / Revenue TTM)
Gross Margin QoQ = 24.34% (prev 25.95%)
Tobins Q-Ratio = 1.04 (Enterprise Value 570.1m / Total Assets 548.6m)
Interest Expense / Debt = 1.12% (Interest Expense 1.39m / Debt 123.6m)
Taxrate = 36.25% (1.09m / 3.01m)
NOPAT = 10.1m (EBIT 15.9m * (1 - 36.25%))
Current Ratio = 4.98 (Total Current Assets 268.5m / Total Current Liabilities 53.9m)
Debt / Equity = 0.34 (Debt 123.6m / totalStockholderEquity, last quarter 363.2m)
Debt / EBITDA = 2.30 (Net Debt 101.1m / EBITDA 44.0m)
Debt / FCF = 2.77 (Net Debt 101.1m / FCF TTM 36.5m)
Total Stockholder Equity = 366.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.74% (Net Income 9.90m / Total Assets 548.6m)
RoE = 2.71% (Net Income TTM 9.90m / Total Stockholder Equity 366.0m)
RoCE = 3.49% (EBIT 15.9m / Capital Employed (Equity 366.0m + L.T.Debt 89.0m))
RoIC = 2.21% (NOPAT 10.1m / Invested Capital 458.8m)
WACC = 6.58% (E(473.9m)/V(597.4m) * Re(8.11%) + D(123.6m)/V(597.4m) * Rd(1.12%) * (1-Tc(0.36)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.77%
[DCF Debug] Terminal Value 77.17% ; FCFF base≈24.7m ; Y1≈16.2m ; Y5≈7.38m
Fair Price DCF = 2.10 (EV 194.6m - Net Debt 101.1m = Equity 93.4m / Shares 44.5m; r=6.58% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -67.33 | EPS CAGR: -53.21% | SUE: 0.40 | # QB: 0
Revenue Correlation: -33.02 | Revenue CAGR: -9.02% | SUE: 0.13 | # QB: 0
EPS current Year (2026-04-30): EPS=0.25 | Chg30d=+0.085 | Revisions Net=+1 | Growth EPS=-24.2% | Growth Revenue=+0.6%
EPS next Year (2027-04-30): EPS=0.28 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+12.0% | Growth Revenue=+3.2%
Additional Sources for SWBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle